Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems.
about
Big data and clinicians: a review on the state of the scienceLevels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study.Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trialsChanges in proliferation kinetics of T cells: a new predictive cellular biomarkers for early rheumatoid arthritis?Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis.Rheumatoid factors: clinical applications.The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis.Anticitrullinated protein/peptide antibodies and rheumatoid factors: two distinct autoantibody systems.The prevalence of rheumatoid factor isotypes and anti-cyclic citrullinated peptides in Malaysian rheumatoid arthritis patients.Rheumatoid factor is correlated with disease activity and inflammatory markers in antineutrophil cytoplasmic antibody-associated vasculitis.Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive.Conversion to seronegative status after abatacept treatment in patients with early and poor prognostic rheumatoid arthritis is associated with better radiographic outcomes and sustained remission: post hoc analysis of the AGREE study.
P2860
Q27012044-6B932D45-E7CC-4B77-87F0-6F34C0659B64Q33873636-C9515185-B665-438B-B28E-6FEA0C15F00DQ35755442-4AC2A115-7815-4500-9BF3-F62B4A635DC0Q36237213-85CD77BC-B079-446C-9721-E6ED55CA5818Q36245951-08DAF95A-C207-4401-B5F9-193F83161629Q37353700-AED3216E-B193-4706-B3DD-765FD0908CBBQ40369679-0DBEDE4B-EEDA-4336-9204-CD4B669F5FB2Q42692933-D41D4F7D-DDAC-4C67-BF9A-62BC00EA35A3Q43687288-31000FBA-753A-4A1D-AB73-5DF7D0421221Q47168681-4C39E3F4-E1EA-4793-B5B4-A5963D9FE7D9Q51137453-9DD53151-9E9D-4C46-A47C-CA5FEBB4F464Q52587105-E995851F-9BD5-46E8-9F8B-BF57192AFC41
P2860
Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Different properties of ACPA a ...... distinct autoantibody systems.
@en
Different properties of ACPA a ...... distinct autoantibody systems.
@nl
type
label
Different properties of ACPA a ...... distinct autoantibody systems.
@en
Different properties of ACPA a ...... distinct autoantibody systems.
@nl
prefLabel
Different properties of ACPA a ...... distinct autoantibody systems.
@en
Different properties of ACPA a ...... distinct autoantibody systems.
@nl
P2093
P2860
P356
P1476
Different properties of ACPA a ...... distinct autoantibody systems.
@en
P2093
Ben A C Dijkmans
Dirkjan van Schaardenburg
Jennie Ursum
Rob J van de Stadt
Wouter H Bos
P2860
P2888
P356
10.1186/AR2704
P577
2009-05-21T00:00:00Z
P5875
P6179
1007282859